Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix PDT.
Phase of Trial: Phase IV
Latest Information Update: 22 Dec 2012
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Actinic keratosis
- Focus Pharmacogenomic; Therapeutic Use
- Sponsors Galderma
- 22 Dec 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-001603-30).
- 23 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jun 2011 Planned end date changed from 1 Dec 2012 to 1 Oct 2011 as reported by ClinicalTrials.gov.